Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Artigo em Inglês | IMSEAR | ID: sea-46749

RESUMO

Staphylococcus aureus (n=84) isolated from the nostrils of a healthy population from Kathmandu and from the infectious cases (n=100) from Tribhuvan University Teaching Hospital, Kathmandu, Nepal were tested from May 1996 to March 1997 in Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal by microbiological and chemical methods to find out their beta lactamase activity. Among the healthy population, in domiciliary conditions 21.4% of the isolates were found beta lactamase producers. The occurrence of beta lactamase producing S. aureus was greater among female (27.0%) than among male (17.0%), however it was not significant (X2 = 1.2309, P > 0.05). The occurrence of the same was observed high among 40 and above age groups (66.7%) and 0-9 age group (60.0%), however no association with any particular age group was observed (X2 = 16.8674, P > 0.05). The b lactamase activity of S. aureus hospital inpatients isolates was 75.0% showing high occurrence of b lactamase activity in hospital isolates compared to S. aureus isolates from healthy carriers (X2 = 52.4113, P < 0.001). No association of beta lactamase positive hospital isolates with gender (X2 = 0.2158, P > 0.05) and age group (X2 = 1.5522, P > 0.05) was observed. This study shows that the prevalence of beta lactamase positive S. aureus was greater in hospital cases than in nasal carriers in domiciliary condition indicating the requisition of further study in this field.


Assuntos
Adolescente , Adulto , Criança , Pré-Escolar , Infecção Hospitalar/enzimologia , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Nepal/epidemiologia , Nariz/microbiologia , Penicilinase/metabolismo , Projetos Piloto , Prevalência , Fatores de Risco , Infecções Estafilocócicas/enzimologia , Staphylococcus aureus/enzimologia , beta-Lactamases/metabolismo
2.
West Indian med. j ; 55(3): 174-182, Jun. 2006.
Artigo em Inglês | LILACS | ID: lil-472324

RESUMO

Detailed clinical data, underlying conditions, inflammatory indices and microbiological parameters in 60 patients who had pure growth of coagulase negative staphylococci from their blood culture specimens at the University Hospital of the West Indies, Jamaica, were analyzed and the clinical significance of the isolates ascertained using standard criteria. This study was undertaken between April and September 2003. The isolates were true pathogens of bloodstream infections in only 5 of the 60 patients (8.4). In the vast majority ie 44 of 60 (73.3) they were mere blood culture contaminants and in 11 (18.3), the clinical significance could not be ascertained Fifteen of the 44 patients (34) with contaminating coagulase negative staphylococci were treated with specific anti-staphylococcal antibiotics; 5 (11.4) with vancomycin. Although there has been a relative increase of coagulase negative staphylococcal infections including bloodstream infections in recent years, the organisms still remain the most common contaminants in blood cultures. Over 70of isolates were contaminants in this study which is similar to that in a number of such studies in other parts of the world The findings underline the need for careful evaluation of coagulase negative staphylococci isolated from blood cultures before instituting therapy to avoid unnecessary use of antibiotics, especially vancomycin, and the consequent increase of antibiotic resistance in hospitals.


Los datos clínicos detallados, las condiciones subyacentes, los índices inflamatorios así como los parámetros microbiológicos de 60 pacientes que presentaron crecimiento puro de estafilococos coagu-lasa-negativos de sus cultivos de sangre en el Hospital Universitario de West Indies, Jamaica, fueron sometidos a análisis. De este modo, se pudo determinar la significación clínica de los aislados, usando criterios estándar. En sólo 5 de los 60 pacientes (8.4%), los aislados resultaron ser realmente pató-genos de infecciones del torrente sanguíneo. En la gran mayoría, a saber 44 de 60 (73.3%), se trataba tan sólo de contaminantes en el cultivo de la sangre, y en 11 (18.3%) no pudo determinarse la impor-tancia clínica. Quince de los 44 pacientes (34%) con estafilococos coagulasa-negativos contaminantes, fueron tratados con antibióticos antiestafilocócicos específicos, y 5 (11.4%) con vancomicina. Aunque en años recientes ha habido un aumento relativo de infecciones por estafilococos coagulasa-negativos – incluyendo infecciones del torrente sanguíneo – los organismos siguen siendo todavía los contamin-antes más comunes en los cultivos de sangre. Más del 70% de los aislados resultaron ser contaminantes en este estudio: un resultado similar al obtenido en una serie de estudios de este tipo realizado en otras partes del mundo. Los hallazgos apuntan a la necesidad de realizar una evaluación cuidadosa de los estreptococos coagulasa-negativos aislados en los cultivos de sangre antes de proceder a instituir la terapia, a fin de evitar el uso innecesario de antibióticos – en especial la vancomicina – y el consiguiente aumento de la resistencia antibiótica en los hospitales.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Antibacterianos/farmacologia , Infecções Estafilocócicas/microbiologia , Sepse/microbiologia , Staphylococcus/isolamento & purificação , Vancomicina/farmacologia , Coagulase , Hospitais Universitários , Infecção Hospitalar/microbiologia , Infecção Hospitalar/prevenção & controle , Infecções Estafilocócicas/sangue , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/enzimologia , Jamaica , Resistência a Medicamentos , Sepse/tratamento farmacológico , Sepse/enzimologia , Staphylococcus/efeitos dos fármacos , Staphylococcus/enzimologia
3.
West Indian med. j ; 55(3): 170-173, Jun. 2006.
Artigo em Inglês | LILACS | ID: lil-472325

RESUMO

The prevalence and significance of coagulase negative staphylococci (CoNS) isolated from blood cultures at the University Hospital of the West Indies (UHWI) during a six-month period were investigated. Standard and automated microbiological procedures were used to process 3001 blood culture specimens received from 2363 patients and 658 (21.9) of the blood cultures yielded 854 bacterial isolates. The highest prevalence of positive blood cultures (60) and the lowest prevalence of blood isolates of CoNS (12) were found in the intensive care unit (ICU). The blood isolates of CoNS were most frequent in the surgical wards (13) and lowest in obstetrics and gynaecology (2). High rates of resistance to methicillin, other anti-staphylococcal penicillins, and cephalosporins used in the treatment of CoNS were observed All blood isolates of CoNS (100) were susceptible to vancomycin. In conclusion, the results show that coagulase-negative staphylococci are the most prevalent bacterial isolates in blood cultures at the UHWI occurring mostly as contaminants. The practice of proper venepuncture and hand-washing techniques by medical staff are recommended to facilitate appropriate antibiotic usage.


Se investigó la prevalencia e importancia de los estafilococos coagulasa negativos (ECoN) aislados de cultivos de sangre en el Hospital Universitario de West Indies (HUWI) por un período de seis meses. Se utilizaron procedimientos microbiológicos estándar y automatizados para procesas 3001 cultivos de sangre recibidos de 2363 pacientes y 658 (21.9%) de los cultivos dieron 854 aislados bacterianos. La más alta prevalencia de cultivos de sangre positivos (60%) y la más baja prevalencia de aislados de ECoN (12%) se encontraron en la Unidad de Cuidados Intensivos (UCI). Los aislados de sangre de ECoN fueron más frecuentes en las salas de cirugía (13%) y más bajos en las de obstetricia y ginecología (2%). Se observaron altas tasas de resistencia a la meticilina, así como a otras penicilinas anti-estafilocócicas y cefalosporinas usadas en el tratamiento de ECoN. Todos los aislados de sangre de ECoN (100%) fueron susceptibles a la vancomicina. En conclusión, los resultados muestran que los estafilococos coagulasa negativos son los aislados bacterianos más prevalentes en cultivos de sangre en el HUWI, presentándose en la mayor parte de los casos como contaminantes. Se recomienda la práctica de técnicas adecuadas de venepuntura y lavado de manos por parte del personal médico a fin de facilitar un uso antibiótico correcto.


Assuntos
Humanos , Hospitais Universitários/estatística & dados numéricos , Infecção Hospitalar/epidemiologia , Infecções Estafilocócicas/epidemiologia , Staphylococcus/isolamento & purificação , Coagulase , Estudos Soroepidemiológicos , Infecção Hospitalar/sangue , Infecção Hospitalar/microbiologia , Infecções Estafilocócicas/sangue , Infecções Estafilocócicas/enzimologia , Jamaica/epidemiologia , Staphylococcus/enzimologia , Testes de Sensibilidade Microbiana , Unidades de Terapia Intensiva
4.
Acta bioquím. clín. latinoam ; 28(3): 405-10, sept. 1994. ilus
Artigo em Espanhol | LILACS | ID: lil-141640

RESUMO

Se aislaron cepas de Staphylococcus aureus resistentes a penicilina y productoras de ß-lactamasas. Mediante el método de dilución en tubos, se calculó la concentración inhibitoria CIM para amoxicilina-sulbactam, con diferente tensión de oxígeno y frente a heparina. Los valores de CIM se redujeron significativamente al sumar sulbactam al antibiótico. La disminución del oxígeno no afectó la capacidad inhibidora de ß-lactamasas del sulbactam, del mismo modo que la presencia de heparina no interfirió en su efecto protector sobre la amoxicilina. Estos resultados reafirmaron el concepto de efectividad de la combinación amoxicilina-sulbactam sobre los procesos infecciosos a S. aureus productores de ß-lactamasas, aun en afecciones donde se genera anaerobiosis relativa y también en enfermos con tratamiento simultáneo con heparina


Assuntos
Amoxicilina/antagonistas & inibidores , Anaerobiose/efeitos dos fármacos , beta-Lactamases/antagonistas & inibidores , Resistência Microbiana a Medicamentos/fisiologia , Infecções Estafilocócicas/tratamento farmacológico , Sulbactam/uso terapêutico , Amoxicilina/uso terapêutico , beta-Lactamases/efeitos adversos , Adjuvantes Farmacêuticos/uso terapêutico , Heparina/efeitos adversos , Infecções Estafilocócicas/enzimologia , Infecções Estafilocócicas/fisiopatologia , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/enzimologia , Sulbactam/antagonistas & inibidores , Sulbactam/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA